THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Matthew Hart to Gene Expression Regulation, Neoplastic

Back to Details
This is a "connection" page, showing publications Matthew Hart has written about Gene Expression Regulation, Neoplastic.
Matthew Hart
Connection Strength
0.079
Gene Expression Regulation, Neoplastic
  1. Targeting DDR2 for Treating Pancreatic Cancer. Mol Cancer Ther. 2025 Oct 01; 24(10):1570-1583.
    View in: PubMed
    Score: 0.049
  2. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 2018; 15(11):1420-1432.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES